A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia.

Derseh, Manaye Tamrie; Solomon, Kiflom; Tamene, Wasihun; Beneberu, Wosenie; Yayehrad, Ashagrachew Tewabe; Ambaye, Abyou Seyfu

Derseh, Manaye Tamrie; Solomon, Kiflom; Tamene, Wasihun; Beneberu, Wosenie; Yayehrad, Ashagrachew Tewabe; Ambaye, Abyou Seyfu.

Afiliación

Derseh MT; Departement of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, Mizan-Tepi University, Mizan-Aman, Ethiopia.
Solomon K; Ayder Teaching Hospital, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Tamene W; Tikur Anbessa Comprehensive Specialized Hospital (TASH), Federal Ministry of Health (FMOH), Addis Ababa, Ethiopia.
Beneberu W; Tikur Anbessa Comprehensive Specialized Hospital (TASH), Federal Ministry of Health (FMOH), Addis Ababa, Ethiopia.
Yayehrad AT; Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Ambaye AS; Departement of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, Mizan-Tepi University, Mizan-Aman, Ethiopia.

Clinicoecon Outcomes Res ; 13: 821-834, 2021.

Article en En | MEDLINE | ID: mdl-34557006

Palabras clave

DVT; Ethiopia; cost effectiveness; rivaroxaban; warfarin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Clinicoecon Outcomes Res Año: 2021 Tipo del documento: Article País de afiliación: Etiopia Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google